Herpes simplex encephalitis: Difference between revisions

From IDWiki
No edit summary
()
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
== Background ==
==Background==


*Infection of the brain parenchyma by [[Herpes simplex virus|HSV]], with a predilection for temporal lobes
*Infection of the brain parenchyma by [[Herpes simplex virus|HSV]], with a predilection for temporal lobes


=== Microbiology ===
===Microbiology===


* More commonly caused by [[HSV-1]] than [[HSV-2]] (which more commonly causes [[aseptic meningitis]])
*More commonly caused by [[HSV-1]] than [[HSV-2]] (which more commonly causes [[aseptic meningitis]])


=== Pathophysiology ===
===Pathophysiology===


* About one-third are from primary infection while two-thirds are from reactivation of latent infection
*About one-third are from primary infection while two-thirds are from reactivation of latent infection


=== Epidemiology ===
===Epidemiology===


* Causes about 10% of [[encephalitis]] cases
*Causes about 10% of [[encephalitis]] cases


==Clinical Manifestations==
==Clinical Manifestations==
Line 25: Line 25:
*Rapidly progressing and can lead to coma
*Rapidly progressing and can lead to coma


== Differential Diagnosis ==
==Differential Diagnosis==


* Other causes of [[encephalitis]]
*Other causes of [[encephalitis]]


==Investigations==
==Investigations==
Line 40: Line 40:
**Normal or slightly low glucose
**Normal or slightly low glucose
**'''HSV PCR''' is confirmatory
**'''HSV PCR''' is confirmatory
**If PCR is negative but suspicion remains high, repeat LP in 3 to 7 days
*EEG
*EEG
**Spikes and slow waves over involved areas
**Spikes and slow waves over involved areas
Line 47: Line 48:
==Management==
==Management==


*May need repeat LP if the first one is negative but suspicion is high
*[[Acyclovir]] 10mg/kg q8h IV for 14 days
*[[Acyclovir]] 10mg/kg q8h IV for 14 days
**Ensure adequate hydration and adjust for renal function
**Ensure adequate hydration and adjust for renal function
**May do longer 14-21 days in immunocompetent patients due to high risk of relapse

==Prognosis==

*15% recover completely
*20% have severe neurologic sequelae
**Primarily dysnomia and impaired new learning
**Also seizures, neuropsychiatric illnesses
*28% mortality even with treatment
*Prognosis is worse with those who are older, are sicker at presentation, or have delayed treatment


[[Category:Herpesviridae]]
[[Category:Herpesviridae]]

Latest revision as of 14:55, 27 April 2021

Background

  • Infection of the brain parenchyma by HSV, with a predilection for temporal lobes

Microbiology

Pathophysiology

  • About one-third are from primary infection while two-thirds are from reactivation of latent infection

Epidemiology

Clinical Manifestations

  • Fever
  • Headache
  • Altered level of consciousness
    • Personality and behavioural changes
  • Focal neuro deficits
  • Seizures
  • Rapidly progressing and can lead to coma

Differential Diagnosis

Investigations

  • Imaging
    • CT head usually normal
    • MRI head can show T2 signal change in temporal lobes
  • Lumbar puncture
    • Elevated protein
    • Lymphocytosis (10-1000 WBCs)
    • Erythrocytes in 80% of cases ("hemorrhagic necrotizing meningoencephalitis")
    • Normal or slightly low glucose
    • HSV PCR is confirmatory
    • If PCR is negative but suspicion remains high, repeat LP in 3 to 7 days
  • EEG
    • Spikes and slow waves over involved areas
    • Periodic lateralized epiieptiform discharges (PLEDs)
    • Usually predominately over involved termporal lobe

Management

  • May need repeat LP if the first one is negative but suspicion is high
  • Acyclovir 10mg/kg q8h IV for 14 days
    • Ensure adequate hydration and adjust for renal function
    • May do longer 14-21 days in immunocompetent patients due to high risk of relapse

Prognosis

  • 15% recover completely
  • 20% have severe neurologic sequelae
    • Primarily dysnomia and impaired new learning
    • Also seizures, neuropsychiatric illnesses
  • 28% mortality even with treatment
  • Prognosis is worse with those who are older, are sicker at presentation, or have delayed treatment